Loading candles…
Alpa Laboratories Ltd, incorporated in 1988 and headquartered in Indore, India, operates in the pharmaceutical industry. The company manufactures and sells drugs and chemicals, focusing on the research, development, and production of pharmaceutical formulations across various therapeutic segments. Its product range includes ethical medicines, generic medicines, over-the-counter (OTC) medicines, injections, tablets, capsules, ointments, and powders. Alpa Laboratories serves markets in India as well as international markets.
This page is a live market overview for ALPA LABORATORIES LTD (ALPA) on the NSE. As a listed security, ALPA LABORATORIES LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ALPA before placing trades on tick2trade.
As of the latest feed, ALPA last traded at ₹68.1 on NSE, down ₹1.87 (2.67%) from the previous close of ₹69.97. Today's session range is ₹67.55 – ₹70.31, against a 52-week band of ₹46.1 – ₹101. Traded volume today stands at 26.66K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for ALPA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ALPA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ALPA LABORATORIES LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ALPA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ALPA option chain page linked from this overview.
| To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters |
| 13 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 28 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.